Inventor
TURECI OZLEM
DE65 patents
⚠️ This page may combine multiple inventors who share the name “TURECI OZLEM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GANYMED PHARMACEUTICALS AG
13 patentsUS10233253B2Mar 19, 2019
Antibodies for treatment of cancer expressing claudin 6
GANYMED PHARMACEUTICALS AG7 citations83
US10053512B2Aug 21, 2018
Antibodies against claudin 18.2 useful in cancer diagnosis
GANYMED PHARMACEUTICALS AG6 citations83
US10314890B2Jun 11, 2019
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer
GANYMED PHARMACEUTICALS AG5 citations82
US9770487B2Sep 26, 2017
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinoma
GANYMED PHARMACEUTICALS AG11 citations82
US10813996B2Oct 27, 2020
Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer
GANYMED PHARMACEUTICALS AG4 citations81
US9775785B2Oct 3, 2017
Antibody to genetic products differentially expressed in tumors and the use thereof
GANYMED PHARMACEUTICALS AG5 citations81
US8961980B2Feb 24, 2015
Monoclonal antibodies for treatment of cancer
GANYMED PHARMACEUTICALS AG5 citations79
US10022444B2Jul 17, 2018
Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer
GANYMED PHARMACEUTICALS AG2 citations70
US8354104B2Jan 15, 2013
Monoclonal antibodies for treatment of cancer
GANYMED PHARMACEUTICALS AG3 citations63
US7429461B2Sep 30, 2008
Genetic products differentially expressed in tumors and use thereof
GANYMED PHARMACEUTICALS AG2 citations63
US11976130B2May 7, 2024
Antibodies against claudin 18.2 useful in cancer diagnosis
GANYMED PHARMACEUTICALS AG0 citations62
US10919974B2Feb 16, 2021
Antibodies for treatment of cancer expressing claudin 6
GANYMED PHARMACEUTICALS AG0 citations61
US9902778B2Feb 27, 2018
Cancer therapy using CLDN6 target-directed antibodies in vivo
GANYMED PHARMACEUTICALS AG1 citations61
SAHIN UGUR
12 patentsUS8168427B2May 1, 2012
Monoclonal antibodies against claudin-18 for treatment of cancer
SAHIN UGUR47 citations95
US8946388B2Feb 3, 2015
Monoclonal antibodies for treatment of cancer
SAHIN UGUR41 citations94
US10117918B2Nov 6, 2018
Antigen-specific T cell receptors and T cell epitopes
SAHIN UGUR18 citations93
US8586047B2Nov 19, 2013
Genetic products differentially expressed in tumors and the use thereof
SAHIN UGUR20 citations93
US9487584B2Nov 8, 2016
Antibodies specific for claudin 6 (CLDN6)
SAHIN UGUR19 citations92
US8425902B2Apr 23, 2013
Monoclonal antibodies against claudin-18 for treatment of cancer
SAHIN UGUR20 citations92
US9718886B2Aug 1, 2017
Cancer therapy using CLDN6 target-directed antibodies in vivo
SAHIN UGUR13 citations91
US9321842B2Apr 26, 2016
Antibodies for treatment of cancer
SAHIN UGUR14 citations91
US9212228B2Dec 15, 2015
Monoclonal antibodies against claudin-18 for treatment of cancer
SAHIN UGUR9 citations91
US9586997B2Mar 7, 2017
Antigen-specific T cell receptors and T cell epitopes
SAHIN UGUR6 citations83
US9216218B2Dec 22, 2015
Monoclonal antibodies for treatment of cancer
SAHIN UGUR11 citations81
US8945923B2Feb 3, 2015
Antigen-specific clonal expansion of B cells
SAHIN UGUR4 citations69
LUDWIG INST CANCER RES
7 patentsUS6548064B1Apr 15, 2003
Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules
LUDWIG INST CANCER RES51 citations96
US6800730B1Oct 5, 2004
Isolated peptides which bind to MHC class II molecules, and uses thereof
LUDWIG INST CANCER RES14 citations93
US6274145B1Aug 14, 2001
Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
LUDWIG INST CANCER RES35 citations92
US6339140B1Jan 15, 2002
SSX family proteins
LUDWIG INST CANCER RES6 citations73
US6291658B1Sep 18, 2001
Isolated nucleic acid molecules encoding SSX family members and thereof
LUDWIG INST CANCER RES6 citations73
US7385044B2Jun 10, 2008
Isolated peptides which bind to MHC Class II molecules, and uses thereof
LUDWIG INST CANCER RES2 citations63
US7270819B2Sep 18, 2007
Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof
LUDWIG INST CANCER RES5 citations63
BIONTECH AG
5 patentsUS10106800B2Oct 23, 2018
Modification of RNA, producing an increased transcript stability and translation efficiency
BIONTECH AG18 citations93
US9194004B2Nov 24, 2015
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG6 citations82
US10604568B2Mar 31, 2020
Diagnosis and therapy of cancer involving cancer stem cells
BIONTECH AG6 citations80
US10093736B2Oct 9, 2018
Agents for treatment of claudin expressing cancer diseases
BIONTECH AG7 citations79
US10724103B2Jul 28, 2020
Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy
BIONTECH AG1 citations71
ASTELLAS PHARMA INC
4 patentsUS11826402B2Nov 28, 2023
Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinoma
ASTELLAS PHARMA INC0 citations61
US10946069B2Mar 16, 2021
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer
ASTELLAS PHARMA INC0 citations61
US12188097B2Jan 7, 2025
Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis
ASTELLAS PHARMA INC0 citations60
US11732308B2Aug 22, 2023
Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis
ASTELLAS PHARMA INC0 citations60
GANYMED PHARMACEUTICALS GMBH
3 patentsUS11859008B2Jan 2, 2024
Antibodies for treatment of cancer expressing claudin 6
GANYMED PHARMACEUTICALS GMBH2 citations71
US11541127B2Jan 3, 2023
Drug conjugates comprising antibodies against claudin 18.2
GANYMED PHARMACEUTICALS GMBH2 citations71
US10927413B2Feb 23, 2021
Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis
GANYMED PHARMACEUTICALS GMBH3 citations69
BIONTECH CELL & GENE THERAPIES GMBH
2 patentsBioNTech SE
2 patentsCORNELL RES FOUNDATION INC
1 patentSLOAN KETTERING INST CANCER
1 patentShowing the top 50 of 65 patents by PatentIndex Score.